Cita APA

Carlo-Stella, C., Zinzani, P. L., Sureda, A., Araújo, L., Casasnovas, O., Carpio Segura, C. d. C., . . . Ribrag, V. (2022). A phase 1/2, open-label, multicenter study of isatuximab in combination with cemiplimab in patients with lymphoma.

Citación estilo Chicago

Carlo-Stella, Carmelo, et al. A Phase 1/2, Open-label, Multicenter Study of Isatuximab in Combination With Cemiplimab in Patients With Lymphoma. 2022.

Cita MLA

Carlo-Stella, Carmelo, et al. A Phase 1/2, Open-label, Multicenter Study of Isatuximab in Combination With Cemiplimab in Patients With Lymphoma. 2022.